自身抗体阴性类风湿性关节炎:仍然是风湿病学家面临的挑战
Serena Bugatti1, Ludovico De Stefano1, Saviana Gandolfo2
1Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy; Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
The Lancet. Rheumatology
|January 22, 2024
概括
自抗体阴性类风湿性关节炎 (RA) 缺乏明确的病原体理解,并带来诊断挑战. 本综述强调了其与自身抗体阳性RA相比的独特特征,以刺激进一步的研究.
科学领域:
- 风湿病学和免疫学
- 自免疫性疾病 自免疫性疾病
- 临床研究 临床研究
背景情况:
- 30年来,对自身抗体阳性类风湿性关节炎 (RA) 的理解取得了重大进展,改善了患者的治疗结果.
- 自体抗体阴性RA在病原体,诊断标准,治疗反应和相关并发症方面仍然定义不佳.
- 基于自身抗体血清型的RA的分类是有争议的,对自身抗体阴性RA的比较研究有限.
研究的目的:
- 与其自身抗体阳性对应物相比,划出自身抗体阴性RA的独特特征.
- 激发讨论并鼓励进一步研究自身抗体阴性RA的复杂性.
主要方法:
- 文献综述侧重于对自身抗体阴性和自身抗体阳性类风湿性关节炎的比较研究.
- 综合有关自身抗体阴性RA的病理生理学,临床表现和管理的当前知识.
- 识别知识缺口和需要进一步研究的领域.
主要成果:
- 自身抗体阴性RA具有独特的诊断挑战,并且可能在治疗反应和并发症概况上有所不同.
- 自体抗体阴性RA背后的病原性机制比血清阳性RA的病原性机制了解得少.
- 现有的专门比较这些RA子集的研究很少,突出显示了重要的知识差距.
结论:
- 自身抗体阴性RA是一种独特的临床实体,需要进一步的专门研究.
- 了解它的特点对于改善诊断,治疗和患者的治疗结果至关重要.
- 本综述旨在促进辩论,并指导未来的研究努力,在这个具有挑战性的类风湿病领域.
相关概念视频
01:29Autoimmune Disorders
442
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
442
01:20Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432